November 20, 2020
A New York federal judge gave preliminary approval Thursday to a $1.75 million class action settlement that would end litigation alleging Canadian pharmaceutical company Correvio Pharma Corp. misled shareholders about the likelihood of a heart drug gaining approval by the U.S. Food and Drug Administration.
July 01, 2020
A Canadian pharmaceutical company asked a New York federal judge Tuesday to toss a proposed stock-drop class action that alleges the company misled shareholders about the likelihood of a drug gaining approval from the U.S. Food and Drug Administration, saying the company was transparent about the process.